These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8568123)

  • 21. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
    Clark DJ; Grove A; Cargill RI; Lipworth BJ
    Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dose and dosing schedule of inhaled budesonide on bone turnover.
    Toogood JH; Jennings B; Hodsman AB; Baskerville J; Fraher LJ
    J Allergy Clin Immunol; 1991 Oct; 88(4):572-80. PubMed ID: 1918724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW; Wisniewski A; Honour J; Tattersfield AE
    Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of spacer device on drug delivery to young children with asthma.
    Agertoft L; Pedersen S
    Arch Dis Child; 1994 Sep; 71(3):217-9; discussion 219-20. PubMed ID: 7979494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis.
    Selroos O; Löfroos AB; Pietinalho A; Niemistö M; Riska H
    Sarcoidosis; 1994 Sep; 11(2):126-31. PubMed ID: 7809497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.
    Weiner P; Weiner M; Azgad Y
    Thorax; 1995 Dec; 50(12):1270-3. PubMed ID: 8553300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler.
    Barry PW; O'Callaghan C
    Br J Clin Pharmacol; 1995 Jul; 40(1):76-8. PubMed ID: 8527272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids.
    Hanania NA; Chapman KR; Sturtridge WC; Szalai JP; Kesten S
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):571-9. PubMed ID: 7499672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.
    Laitinen LA; Laitinen A; Haahtela T
    J Allergy Clin Immunol; 1992 Jul; 90(1):32-42. PubMed ID: 1629507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients.
    Pauwels RA; Hargreave FE; Camus P; Bukoski M; Ståhl E
    Chest; 1996 Jul; 110(1):53-7. PubMed ID: 8681664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ; Lipworth BJ
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled budesonide vs prednisone in the maintenance treatment of pulmonary sarcoidosis.
    Zych D; Pawlicka L; Zielinski J
    Sarcoidosis; 1993 Mar; 10(1):56-61. PubMed ID: 8134718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.
    Grahnén A; Eckernäs SA; Brundin RM; Ling-Andersson A
    Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic availability and lung deposition of budesonide via three different nebulizers in adults.
    Dahlström K; Thorsson L; Larsson P; Nikander K
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):226-32. PubMed ID: 12602671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
    Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhaled budesonide for chronic obstructive pulmonary disease].
    Weiner P; Zamir D; Beckerman M
    Harefuah; 1997 Jun; 132(11):756-9, 823. PubMed ID: 9223815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group.
    Nelson HS; Bernstein IL; Fink J; Edwards TB; Spector SL; Storms WW; Tashkin DP
    Chest; 1998 May; 113(5):1264-71. PubMed ID: 9596304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.